Intuitive Surgical, Inc. $ISRG Position Increased by Generali Investments CEE investicni spolecnost a.s.

Generali Investments CEE investicni spolecnost a.s. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 82.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,516 shares of the medical equipment provider’s stock after purchasing an additional 687 shares during the period. Generali Investments CEE investicni spolecnost a.s.’s holdings in Intuitive Surgical were worth $824,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on ISRG shares. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. UBS Group lifted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Truist Financial boosted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Thirteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Stock Up 1.8%

Shares of NASDAQ ISRG opened at $447.23 on Wednesday. The stock’s fifty day simple moving average is $466.61 and its 200 day simple moving average is $500.97. The stock has a market capitalization of $160.32 billion, a price-to-earnings ratio of 62.38, a PEG ratio of 4.60 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.78 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.